|
| Press Releases |
|
 |
|
| Tuesday, June 12, 2018 |
|
|
Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials |
| Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/ more info >> |
|
| Friday, May 18, 2018 |
|
|
Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials |
| Leading Asia Pacific CRO Novotech commended the Turnbull Government's Federal Budget decision to exclude clinical trials activity from a A$4m cap on cash refunds, or any lifetime cap on refunds. more info >> |
|
| Friday, June 23, 2017 |
|
|
Novotech signs Central Lab Services Agreement with Sonic Clinical Trials |
| Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an affiliate of international healthcare company, Sonic Healthcare. more info >> |
|
| Tuesday, April 18, 2017 |
|
|
Novotech signs MOU with South Korea's leading medical center, the Asan Medical Center |
| Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea's largest medical institution - The Asan Medical Center's (AMC) Clinical Trial Center. The MOU formalises Novotech's relationship with the internationally-leading medical center and its principal investigators. more info >> |
|
| Thursday, March 9, 2017 |
|
|
New Research reveals Asia poised as Preferred Destination for Clinical Trials |
| Frost & Sullivan released a white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific CRO Novotech presenting the findings to an audience of senior biotechnology and pharmaceutical executives in a private event at the Outsourcing in Clinical Trials - West Coast (OCT-WC 2017) conference, held Feb 22-23 in Burlingame, Ca. (USA). more info >> |
|
| Friday, March 3, 2017 |
|
|
New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials |
| Frost & Sullivan released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific specialist CRO Novotech. Research from the new white paper revealed Asia is quickly becoming a clinical research powerhouse. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Hitachi High-Tech Announces the SU9600: Next-Generation Ultrahigh-Resolution Scanning Electron Microscope with High Throughput
Oct 31, 2025 0:45 JST
|
|
|
Sharp to Introduce AQUOS sense10 Smartphone
Oct 31, 2025 0:27 JST
|
|
|
Fujitsu to provide digital ticketing service for NTT DOCOMO's new d ticket platform
Oct 31, 2025 0:07 JST
|
|
|
EESystem Triumphs Again: Courts Deem Jason Shurka's Claims "Baseless" and "Futile"
Oct 31, 2025 21:45 HKT/SGT
|
|
|
Autumn Lighting Fair, Outdoor and Tech Light Expo, Eco Expo Asia draw some 62,000 buyers
Oct 31, 2025 19:56 HKT/SGT
|
|
|
Saudi Arabia Assumes Chairmanship of INTOSAI
Oct 31, 2025 19:45 HKT/SGT
|
|
|
T-RIZE Strategically Collaborates with Republic and Canton to Launch the First New Construction Real Estate Equity Tokenization Deal on Canton Network, phase one of a $200M plan
Oct 31, 2025 15:50 HKT/SGT
|
|
|
IPO Watch - High-Margin International Business Scales Up Rapidly: Unpacking Hithium Energy Storage's Global Expansion Ambition Behind its Push for a Hong Kong Listing 
Oct 31, 2025 15:20 HKT/SGT
|
|
|
CIMC Group Announces the First Three Quarter Results for 2025
Oct 31, 2025 14:16 HKT/SGT
|
|
|
Hong Kong delegation concludes mission in Riyadh
Oct 31, 2025 11:19 HKT/SGT
|
|
|
The Executive Centre Unveils New Premium Flexible Workspace at One IFC, Central Hong Kong
Oct 31, 2025 09:19 HKT/SGT
|
|
|
Doubleview Gold Corp Announces Non-Brokered Private Placement of Flow-Through Shares at $1.00 per share along with Non-Flow-Through Units
Oct 31, 2025 09:09 HKT/SGT
|
|
|
HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus
Oct 31, 2025 9:30 JST
|
|
|
TruMerit's Peter Preziosi Elected President of the Conference of NGOs in Consultative Relationship With the United Nations
Oct 31, 2025 04:00 HKT/SGT
|
|
|
MHI and Nippon Shokubai to Develop Ammonia Cracking System for NEDO's "Development of Technologies for Building a Competitive Hydrogen Supply Chain" Project
Oct 30, 2025 23:14 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
